Viewing Study NCT03791112


Ignite Creation Date: 2025-12-26 @ 10:43 PM
Ignite Modification Date: 2026-03-02 @ 8:03 PM
Study NCT ID: NCT03791112
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-27
First Post: 2018-12-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study of BPI-16350 in Patients with Advanced Solid Tumor
Sponsor: Betta Pharmaceuticals Co., Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: BTP-66711
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators